Literature DB >> 27137208

Immune thrombocytopenia in ulcerative colitis.

G Casella1, E Antonelli2, V Villanacci3, M Salemme3, C Di Bella4, V Baldini5, G Bassotti6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27137208     DOI： 10.1007/s10151-016-1471-1

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  5 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  Inflammatory bowel disease associated with immune thrombocytopenic purpura in children.

Authors:  L M Higuchi; S Joffe; E J Neufeld; S Weisdorf; J Rosh; S Murch; A Devenyi; J F Thompson; J D Lewis; A Bousvaros
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-11       Impact factor: 2.839

Review 3.  Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation?

Authors:  J Zlatanic; B I Korelitz; N Wisch; P Kim; M Ammirati; S Schwarz; S Gruenstein; L Lipsey
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

4.  Immune thrombocytopenic purpura in patients with ulcerative colitis.

Authors:  Yohei Mizuta; Hajime Isomoto; Yoshiko Kadokawa; Yuko Akazawa; Shunzen Chin; Yusei Kanazawa; Fuminao Takeshima; Katsuhisa Omagari; Kunihiko Murase; Terumitsu Sawai; Tohru Nakagoe; Ikuo Murata; Shigeru Kohno
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

5.  Immune thrombocytopenic purpura in ulcerative colitis: a case report and systematic review.

Authors:  Subhash Chandra; Sarah Finn; Eugene Obah
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-04-14
  5 in total
  1 in total

1.  Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial.

Authors:  Lijun Peng; Yan Zhong; Aiping Wang; Zhisheng Jiang
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.